UNITED CAPITAL FINANCIAL ADVISORS, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 344 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
UNITED CAPITAL FINANCIAL ADVISORS, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$962,000
-56.7%
12,905
-0.9%
0.01%
-61.5%
Q4 2020$2,220,000
+29.5%
13,020
+7.3%
0.01%
+18.2%
Q3 2020$1,714,000
-18.1%
12,131
-7.0%
0.01%
-26.7%
Q2 2020$2,093,000
+41.6%
13,051
-13.6%
0.02%
+25.0%
Q1 2020$1,478,000
+28.9%
15,114
-0.7%
0.01%
+50.0%
Q3 2019$1,147,000
-51.7%
15,223
-2.6%
0.01%
-50.0%
Q2 2019$2,374,000
+33.0%
15,623
+4.3%
0.02%
+23.1%
Q1 2019$1,785,000
+11.4%
14,980
+2.0%
0.01%0.0%
Q4 2018$1,603,000
-50.9%
14,692
-27.4%
0.01%
-43.5%
Q3 2018$3,267,000
+21.6%
20,227
-0.4%
0.02%
+15.0%
Q2 2018$2,686,000
+38.8%
20,317
-22.2%
0.02%
+33.3%
Q1 2018$1,935,000
+30.8%
26,111
-0.0%
0.02%
+25.0%
Q4 2017$1,479,000
+28.1%
26,121
+2.6%
0.01%
+20.0%
Q3 2017$1,155,000
+34.6%
25,471
+0.1%
0.01%
+25.0%
Q2 2017$858,000
+13.8%
25,4580.0%0.01%
+14.3%
Q1 2017$754,000
+8.0%
25,4580.0%0.01%0.0%
Q4 2016$698,000
-55.3%
25,458
-0.0%
0.01%
-53.3%
Q3 2016$1,563,000
+173.7%
25,459
-15.3%
0.02%
+150.0%
Q2 2016$571,000
-2.6%
30,0440.0%0.01%0.0%
Q1 2016$586,000
-49.4%
30,0440.0%0.01%
-53.8%
Q4 2015$1,159,000
+20.1%
30,0440.0%0.01%
+8.3%
Q3 2015$965,000
+5.6%
30,0440.0%0.01%
+9.1%
Q2 2015$914,000
+156.7%
30,044
+2.9%
0.01%
+175.0%
Q1 2015$356,00029,2110.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Ikarian Capital, LLC 399,400$35,962,0005.36%
Avoro Capital Advisors LLC 3,125,000$281,406,0004.79%
Varenne Capital Partners 324,661$29,236,0004.34%
Evolutionary Tree Capital Management, LLC 96,695$8,707,0004.18%
Ally Bridge Group (NY) LLC 120,000$10,806,0003.78%
Casdin Capital, LLC 1,350,000$121,568,0003.43%
Ghost Tree Capital, LLC 100,000$9,005,0003.23%
GREAT POINT PARTNERS LLC 145,405$13,094,0002.91%
Camber Capital Management LP 825,000$74,291,0002.55%
Alpha DNA Investment Management LLC 17,522$1,577,0001.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders